https://www.selleckchem.com/pr....oducts/Temsirolimus.
Copyright © 2020 Hou, Ó hAilín, Vogel and Hanashima.Heterogeneity between late-onset Parkinson's disease (LOPD) and early-onset Parkinson's disease (EOPD) is mainly reflected in the following aspects including genetics, disease progression, drug response, clinical manifestation, and neuropathological change. Although many studies have investigated these differences in relation to clinical significance, the functional processing circuits and underlying neural mechanisms have not been entirely understood. In this study, regional homo
Like
Comment
Share
